INHIBITORY EFFECTS OF SUBSTRATE-BASED BCR-ABL1 KINASE INHIBITORS ON THE GROWTH OF CHRONIC MYELOID LEUKEMIA CELL LINE K562

被引：0

作者：

Huang, Y. -H. ^{[1
]}

Henriques, S. Troeira ^{[1
]}

Lawrence, N. ^{[1
]}

Kaas, Q. ^{[1
]}

Craik, D. J. ^{[1
]}

机构：

[1] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia

来源：

JOURNAL OF PEPTIDE SCIENCE | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

PP IX-257

引用

页码：S174 / S174

页数：1

共 50 条

[31] Secondary fusions as a mechanism of BCR-ABL1 kinase-independent resistance in chronic myeloid leukemia [J].

Barnes, Evan J. ;

Eide, Christopher A. ;

Bottomly, Daniel ;

Wilmot, Beth ;

McWeeney, Shannon K. ;

Tognon, Cristina E. ;

Druker, Brian J. .

CANCER RESEARCH, 2021, 81 (13)

[32] Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors [J].

Pietarinen, Paavo O. ;

Eide, Christopher A. ;

Ayuda-Duran, Pilar ;

Potdar, Swapnil ;

Kuusanmaki, Heikki ;

Andersson, Emma I. ;

Mpindi, John P. ;

Pemovska, Tea ;

Kontro, Mika ;

Heckman, Caroline A. ;

Kallioniemi, Olli ;

Wennerberg, Krister ;

Hjorth-Hansen, Henrik ;

Druker, Brian J. ;

Enserink, Jorrit M. ;

Tyner, Jeffrey W. ;

Mustjoki, Satu ;

Porkka, Kimmo .

ONCOTARGET, 2017, 8 (14) :22606-22615

[33] BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients [J].

McCarron, Sarah L. ;

O'Connor, Lisa M. ;

Langabeer, Stephen E. ;

Conneally, Eibhlin .

GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (02) :170-173

[34] The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells [J].

Rowley, PT ;

Keng, PC ;

Kosciolek, BA .

LEUKEMIA RESEARCH, 1996, 20 (06) :473-480

[35] Evaluation of the Apoptotic Effects of the Humic Acid Treatment on Chronic Myeloid Leukemia Cell Line K562 [J].

Tiber, Pinar Mega ;

Balci-Okcanoglu, Tugce ;

Karadeniz, Melike ;

Aykac, Asli .

CYPRUS JOURNAL OF MEDICAL SCIENCES, 2021, 6 (02) :157-161

[36] Transferred BCR/ABL DNA from K562 Extracellular Vesicles Causes Chronic Myeloid Leukemia in Immunodeficient Mice [J].

Cai, Jin ;

Wu, Gengze ;

Tan, Xiaorong ;

Han, Yu ;

Chen, Caiyu ;

Li, Chuanwei ;

Wang, Na ;

Zou, Xue ;

Chen, Xinjian ;

Zhou, Faying ;

He, Duofen ;

Zhou, Lin ;

Jose, Pedro A. ;

Zeng, Chunyu .

PLOS ONE, 2014, 9 (08)

[37] Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study [J].

Abu Seman, Zahidah ;

Ahid, Fadly ;

Kamaluddin, Nor Rizan ;

Sahid, Ermi Neiza Mohd ;

Esa, Ezalia ;

Said, Siti Shahrum Muhamed ;

Azman, Norazlina ;

Mat, Wan Khairull Dhalila Wan ;

Abdullah, Julia ;

Ali, Nurul Aqilah ;

Khalid, Mohd Khairul Nizam Mohd ;

Yusoff, Yuslina Mat .

BMC RESEARCH NOTES, 2024, 17 (01)

[38] PROPERTIES OF K562 CELL LINE, DERIVED FROM A PATIENT WITH CHRONIC MYELOID LEUKEMIA [J].

KLEIN, E ;

BENBASSAT, H ;

NEUMANN, H ;

RALPH, P ;

ZEUTHEN, J ;

POLLIACK, A ;

VANKY, F .

INTERNATIONAL JOURNAL OF CANCER, 1976, 18 (04) :421-431

[39] Comment on "Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors" [J].

Kim, Sung-Hyun ;

Kim, Dong-Wook .

HAEMATOLOGICA, 2015, 100 (03) :E120-E121

[40] ND-09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR-ABL signaling ( vol 46, 136, 2021) [J].

Liu, Yan-Hong ;

Zhu, Man ;

Lei, Pan-Pan ;

Pan, Xiao-Yan ;

Ma, Wei-Na .

ONCOLOGY REPORTS, 2025, 53 (03)

← 1 2 3 4 5 →